EDGE THERAPEUTICS INC's ticker is EDGE and the CUSIP is 279870109. A total of 39 filers reported holding EDGE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $29,893,000 | -12.7% | 3,190,222 | -0.1% | 0.01% | -17.6% |
Q3 2017 | $34,254,000 | +25.4% | 3,192,272 | +19.9% | 0.02% | +21.4% |
Q2 2017 | $27,324,000 | +13.9% | 2,663,123 | +1.1% | 0.01% | +16.7% |
Q1 2017 | $23,987,000 | -24.0% | 2,633,023 | +4.3% | 0.01% | -25.0% |
Q4 2016 | $31,543,000 | +21.5% | 2,523,423 | +1.2% | 0.02% | +14.3% |
Q3 2016 | $25,968,000 | +7.4% | 2,494,596 | +4.3% | 0.01% | +7.7% |
Q2 2016 | $24,188,000 | +10.5% | 2,392,496 | -0.0% | 0.01% | +8.3% |
Q1 2016 | $21,898,000 | -19.1% | 2,393,296 | +4.3% | 0.01% | -14.3% |
Q4 2015 | $27,064,000 | – | 2,294,566 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |